Insulin cost reform absent from new Senate Democratic drug pricing proposal

Published



Insulin cost reform is absent from a new Senate Democratic measure for lowering drug prices, an omission that could spell trouble for the embattled party come November.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.